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Introduction
The incidence of neurotoxic events due to intravascular applica-
tion of iodinated x-ray contrast media (CM) has decreased markedly
since the introduction of nonionic CM [1]. Severe neurotoxic compli-
cations are accompanied by disruption of the blood-brain barrier and
CM extravasation [1–6]. Coronary angiography involving only non-
ionic CM has been reported to cause transient cortical blindness,
confusion and amnesia, but no focal deficits [3, 4], whereas coronary
angiography involving ionic CM was followed by more severe com-
plications including seizures, motor and speech deficits [5, 6]. Here
we report on a patient who developed transient hemiparesis, aphasia
and confusion due to neurotoxicity of nonionic CM after coronary
angiography, and whose CT findings mimicked subarachnoid hem-
orrhage (SAH).
Case Report
An 82-year-old right-handed Caucasian woman with progressive
angina underwent transfemoral coronary angioplasty with stent
placement. Her medical history included arterial hypertension and
unilateral nephrectomy, but no neurological antecedents. Baseline
serum creatinine levels were marginally elevated at 106 ÌM, reflect-
ing F50% impairment in glomerular filtration. The angiographic
intervention took 134 min and required the injection of 500 ml of
iomeprol (IomeronTM 350, Bracco SpA, Italy), a monomeric non-
ionic CM. Additional treatment included 7,500 IU heparin, 300 mg
clopidogrel and 100 mg aspirin. Before and during the intervention,
the patient had no neurological deficits. However, 30 min after the
Fig. 1. Time series of brain CT scans from a
patient with nonionic contrast neurotoxicity
after coronary angiography. Bihemispheric
sulcal subarachnoid contrast enhancements
at 6 h (a) and 12 h (b), fading at 21 h (c), and
completely cleared at 45 h (d). Note head
rotation to the left (a) corresponding to right
hemiparesis.
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Fig. 2. Diffusion-weighted MRI with a b-value of 1,000 of the same anatomical region which displayed a contrast
enhancement in the CCT. No sign of an acute or subacute stroke is visible.
procedure she became increasingly disoriented and drowsy. Her
blood pressure rose to 200/100 mm Hg. Within the following 4 h, she
became aphasic and developed right hemiparesis. Cranial CT, per-
formed first without and then with additional administration of
80 ml Iomeron 300, revealed hyperdense material filling the sulci of
both brain hemispheres, which was diagnosed as SAH (fig. 1a).
At this time the patient was referred to our acute stroke unit. On
admission, 9 h postintervention, she exhibited severe global aphasia,
mild to moderate right hemiparesis, meningism, confusion and som-
nolence. Blood pressure was 150/65 mm Hg. CT was repeated, con-
firming bihemispheric hyperdense filling of the cerebral sulci, which
was more prominent on the left hemisphere (fig. 1b). Cranial Dopp-
ler ultrasonography detected no pathologic flow signals. Twenty-four
hours postevent, lumbar CSF analysis yielded normal standard
results concerning cell count and protein content; particularly neither
xanthochromia nor red blood cells were seen. Cerebral MRI compil-
ing T1, T2, gradient echo, FLAIR, proton density, spin echo, diffu-
sion-weighted sequences and MR angiography excluded hemorrhage,
ischemia, or any other significant pathology besides mild hyperten-
sive microangiopathy and dilative arteriopathy. There was no gadol-
inium enhancement. Figure 2 shows the normal diffusion-weighted
MRI images of the same regions displaying the CCT contrast en-
hancement. There was no sign of cerebral ischemia.
Spontaneous recovery was observed within 40 h postangiogra-
phy. The patient fully regained consciousness, orientation, language
ability, and muscular strength. In parallel, as observed with repeat
CT scans, sulcal hyperdensities partly faded after 21 h (fig. 1c) and
totally disappeared within 45 h (fig. 1d). Serum creatinine, which
had risen to 141 ÌM intermediately, returned to baseline levels
(115 ÌM ). The patient was monitored 3 more days before release.
Follow-up interviews 1 and 4 weeks later confirmed that the patient
had no sequelae other than persistent amnesia obscuring the 24-hour
period immediately following angiography. Seizures were never ob-
served.
Chemical assessment of iomeprol concentrations (kindly per-
formed by Dr Lorusso, Bracco SpA) revealed a strong enrichment of
iomeprol in the lumbar CSF (547 Ìg/ml) as compared to the simulta-
neous serum sample (129 Ìg/ml) 24 h after coronary angiography.
Voxel density measurements within the initial CT scan showed that
the subarachnoidal hyperdensities reached up to 96 Hounsfield
units.
Discussion
To our knowledge, this is the first case illustrating the occurrence
of focal deficits such as hemiparesis and aphasia following coronary
angiographic application of nonionic CM. Furthermore, our case
shows that CT findings due to CM extravasation can be indistin-
guishable from SAH, so that the correct diagnosis requires further
investigations. As presented here, routine CSF analysis and MRI
excluded SAH. Special CSF analysis confirmed iomeprol enrichment
in the CSF as the cause of subarachnoid contrast enhancement. This
was also consistent with voxel densities reaching as much as 96
Hounsfield units, clearly exceeding blood density ranging from 40 to
60 units [5]. CM enrichment in the CSF is a consequence of CM-
toxic blood-brain/blood-CSF barrier disruption followed by CM
extravasation [1]. A subacute stroke as the source of a disturbed
blood-brain barrier could be excluded by the MRI findings with a
normal diffusion-weighted image of the same anatomical region
which displayed contrast enhancement in the sulci in the CCT
Although the administration of 500 ml Iomeron 350 was just
below the maximum recommended dose for coronary angiography as
indicated by the manufacturer, it may be regarded as a relative over-
dosage in our patient with underlying chronic renal function impair-
ment. Taking this into account, an additional dose, as given here for
contrast CT, should have been avoided.
In conclusion, apparent SAH following any intravascular applica-
tion of any CM has to be clarified by lumbar puncture and/or MRI,
even if CT strongly suggests SAH, in order to avoid additional CM
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administration and toxicity as well as further risks associated with
cerebral angiography, which is required in the case of true SAH.
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